Veradermics Inc (MANE)

$37.16 -0.59 (-1.56%)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 934,600
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Veradermics, Incorporated operates as a biopharmaceutical company focused on developing novel therapeutics for dermatologic and aesthetic conditions. The company develops treatments for Pattern Hair Loss affecting adults and children. The company's products include VDPHL01, an oral, non-hormonal treatment for men and women with PHL for chronic hair loss therapy. Additionally, it engages in the development of VDMN, a dissolvable microarray patch technology for immunotherapy of common warts; VDAA...

Industry: Biotechnology
Sector: Healthcare
Phone: (228) 372-3376
Address:
470 James Street, Suite 14, New Haven, United States
xelaxela
xelaxela Feb. 19 at 11:52 PM
$MANE Seems like nobody is trading this thing
0 · Reply
StormSurgeX
StormSurgeX Feb. 17 at 6:52 PM
$MANE $AGX $IRDM $TMDE =*=
0 · Reply
THSSKS
THSSKS Feb. 8 at 5:20 PM
$MANE massively underfunded and overvalued bioturd, but huge tam for mpb. Company is essentially broke, if investment bankers push it up for an offering, I’ll be shorting the hell outta this time released rogaine stock.
1 · Reply
Pranee2023
Pranee2023 Feb. 6 at 7:28 PM
$MANE oral minoxidil.
0 · Reply
JayBullsEye
JayBullsEye Feb. 5 at 2:14 PM
$MANE
0 · Reply
VinnyVelvet
VinnyVelvet Feb. 5 at 5:43 AM
$MANE How we feeling about his today?
0 · Reply
Latest News on MANE
NYSE Content Update: Forgent Power Solutions, Post IPO, to Ring Opening Bell

Feb 12, 2026, 8:55 AM EST - 16 days ago

NYSE Content Update: Forgent Power Solutions, Post IPO, to Ring Opening Bell

FPS

Veradermics Completes Enrollment in Second Pivotal Phase 3 Clinical Trial of VDPHL01 for Male Pattern Hair Loss

Feb 9, 2026, 7:30 AM EST - 19 days ago

Veradermics Completes Enrollment in Second Pivotal Phase 3 Clinical Trial of VDPHL01 for Male Pattern Hair Loss

U.S. IPO Weekly Recap: 7 IPOs Make It One Of The Busiest Weeks In 4 Years

Feb 6, 2026, 10:00 PM EST - 21 days ago

U.S. IPO Weekly Recap: 7 IPOs Make It One Of The Busiest Weeks In 4 Years

AGBK AGMB OXY ARKO BOBS CEPS EIKN

Veradermics Announces Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares in Initial Public Offering

Feb 5, 2026, 4:05 PM EST - 22 days ago

Veradermics Announces Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares in Initial Public Offering

Veradermics Announces Pricing of Upsized Initial Public Offering

Feb 3, 2026, 9:57 PM EST - 24 days ago

Veradermics Announces Pricing of Upsized Initial Public Offering

Veradermics Finalizes $200 Million IPO Target

Feb 2, 2026, 1:28 PM EST - 25 days ago

Veradermics Finalizes $200 Million IPO Target

Veradermics, Dermatology Biopharma Focused on Hair Loss, Files for NYSE IPO

Jan 9, 2026, 5:08 PM EST - 7 weeks ago

Veradermics, Dermatology Biopharma Focused on Hair Loss, Files for NYSE IPO

Veradermics IPO Registration Document (S-1)

Jan 9, 2026, 5:04 PM EST - 7 weeks ago

Veradermics IPO Registration Document (S-1)

Hair loss biotech Veradermics files for a $100 million IPO

Jan 9, 2026, 3:13 PM EST - 7 weeks ago

Hair loss biotech Veradermics files for a $100 million IPO

xelaxela
xelaxela Feb. 19 at 11:52 PM
$MANE Seems like nobody is trading this thing
0 · Reply
StormSurgeX
StormSurgeX Feb. 17 at 6:52 PM
$MANE $AGX $IRDM $TMDE =*=
0 · Reply
THSSKS
THSSKS Feb. 8 at 5:20 PM
$MANE massively underfunded and overvalued bioturd, but huge tam for mpb. Company is essentially broke, if investment bankers push it up for an offering, I’ll be shorting the hell outta this time released rogaine stock.
1 · Reply
Pranee2023
Pranee2023 Feb. 6 at 7:28 PM
$MANE oral minoxidil.
0 · Reply
JayBullsEye
JayBullsEye Feb. 5 at 2:14 PM
$MANE
0 · Reply
VinnyVelvet
VinnyVelvet Feb. 5 at 5:43 AM
$MANE How we feeling about his today?
0 · Reply